Assessment of Autonomic Nervous Regulation During Postnatal Period in Newborns
1 other identifier
observational
75
1 country
1
Brief Summary
The project aims to assess the regulatory mechanisms of autonomic nervous system using noninvasive methods in newborns during postnatal adaptation period. Evaluated parameters will include complex analysis of electrodermal activity as a parameter reflecting sympathetic cholinergic system and indices of heart rate variability reflecting the activity of parasympathetic cardiac regulation. The project is focused on the neuro-psycho-physiological characteristics of physiological adaptation in early postnatal age and the effect of non-pharmacological pain relieving.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 26, 2018
CompletedFirst Posted
Study publicly available on registry
February 5, 2019
CompletedStudy Start
First participant enrolled
February 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedJanuary 4, 2022
January 1, 2022
3.6 years
November 26, 2018
January 3, 2022
Conditions
Outcome Measures
Primary Outcomes (5)
Characteristics of parasympathetic (vagal) heart regulation in newborns in relation to nociception
The study of cardiac vagal regulation of heart rate in relation to nociceptive stimulus using conventional linear and novel nonlinear analysis of heart rate variability (HRV) by special software (Kubios HRV, University of Eastern Finland, Kuopio, Finland). Continual recordings of RR intervals will be recorded using Polar V800 (Polar, Finland). HRV indices: linear (time domain - mean square of successive differences (MSSD); spectral domain - low frequency power (LF), high frequency power (HF), total spectral power (TP); non-linear (symbolic dynamics - 0V%, 2LV%, entropy).
within the first 4 days of postnatal life
Characteristics of sympathetic activity in newborns in relation to nociception
The study of sympathetic cholinergic system indexed by electrodermal activity (EDA) using linear and novel nonlinear parameters characterizing complex sympathetic behavior in relation to nociceptive stimulus. Continual EDA recording associated with peripheral temperature monitoring will be performed using device BioInfinity, Thought Technology Ltd., Canada. EDA indices: linear - SCA (skin conductance amplitude), frequency of NS-EDR (nonspecific electrodermal responses), nonlinear - SIE (symbolic information entropy), and ApEn (approximate entropy).
within the first 4 days of postnatal life
Autonomic (parasympathetic) reactivity in response to non-pharmacological pain relief in newborns
The study of autonomic nervous system complex regulatory mechanisms included in the reactivity - test: stress stimulus (painful intervention) with non-pharmacological pain relieving and recovery phase using HRV quantitative and qualitative analysis. 1st group (control group, n=25) without pain relief; 2nd group (n=25) with oral application of sucrose during nociception stimulus; 3rd group (n=25) with oral application of mother milk during nociceptive stimulus.
within the first 4 days of postnatal life - during and after pain stimulus
Autonomic (sympathetic) reactivity in response to non-pharmacological pain relief in newborns
The study of autonomic nervous system complex regulatory mechanisms included in the reactivity - test: stress stimulus (painful intervention) with non-pharmacological pain relieving and recovery phase using EDA quantitative and qualitative analysis. 1st group (control group, n=25) without pain relief; 2nd group (n=25) with oral application of sucrose during nociception stimulus; 3rd group (n=25) with oral application of mother milk during nociceptive stimulus.
within the first 4 days of postnatal life - during and after pain stimulus
Pain quality assessment in newborns: Neonatal Facial Coding System (NFCS) scaling system
Assessment of the pain quality during painful intervention in newborns associated with muscular application of K vitamin after birth and heel lancing (blood spot) on 3rd postnatal day (standard neonatal care) according to Neonatal Facial Coding System (NFCS). NFCS: visual monitoring of newborn's face during pain stimulus for the presence of 9 specific facial actions: brow bulge, eye squeeze, naso - labial furrow, open lips, stretch mouth (horizontal/vertical), lip purse, taut tongue, chin quiver. Scale range: 0 - 9 points; (0 = no pain; 9 = maximal pain presentation).
within the first 4 days of postnatal life - during pain stimulus
Secondary Outcomes (18)
Developmental aspect of parasympathetic regulatory mechanisms in early postnatal period
early after birth; 24 hours of life; 3rd - 4th day of life
Developmental aspect of sympathetic regulatory mechanisms in early postnatal period
early after birth; 24 hours of life; 3rd - 4th day of life
Maternal clinical parameters effect on the neonatal autonomic (sympathetic) nervous system regulation
prior to delivery + retrospective data
Maternal clinical parameters effect on the neonatal autonomic (parasympathetic) nervous system regulation
prior to delivery + retrospective data
Delivery mode effect on autonomic (sympathetic) nervous system regulation
at the time of delivery
- +13 more secondary outcomes
Study Arms (3)
Control group
Healthy term newborns without pain relief during pain stimulus (intramuscular K vitamin administration and heel lancing for blood spot examination).
Sucrose group
Healthy term newborns with oral application of sucrose during pain stimulus (intramuscular K vitamin administration and heel lancing for blood spot examination).
Mother milk group
Healthy term newborns with oral application of mother milk during pain stimulus (intramuscular K vitamin administration and heel lancing for blood spot examination).
Interventions
Pain stimulus - intramuscular K vitamin administration, heel lancing = standard healthcare procedure
Administration of sucrose/mother milk during pain stimulus
Eligibility Criteria
Healthy term newborns with physiological postnatal adaptation born in University Hospital in Martin (Slovakia).
You may qualify if:
- healthy term newborns
- physiological postnatal adaptation
- signed parental informed consent
You may not qualify if:
- preterm delivery
- impaired postnatal adaptation
- perinatal infection
- congenital diseases and genetic anomalies
- hypoglycemia
- hyperbilirubinemia requiring phototherapy treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jessenius Medical Faculty, Comenius University
Martin, 03601, Slovakia
Study Officials
- STUDY DIRECTOR
Mirko Zibolen, Prof, MD
Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 26, 2018
First Posted
February 5, 2019
Study Start
February 15, 2019
Primary Completion
October 1, 2022
Study Completion
December 31, 2022
Last Updated
January 4, 2022
Record last verified: 2022-01